Navigation Links
Mylan Announces Pricing of Senior Notes
Date:12/4/2015

HERTFORDSHIRE, England and PITTSBURGH, Dec. 4, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the pricing of a private placement of $1 billion aggregate principal amount of senior notes, comprised of $500 million aggregate principal amount of 3.000% senior notes due 2018 at an issue price of 99.874% and $500 million aggregate principal amount of 3.750% senior notes due 2020 at an issue price of 99.968%. Mylan intends to use the net proceeds from the offering to repay the amounts outstanding under its revolving credit facility and its accounts receivable securitization facility and to finance a portion of the repurchase of its ordinary shares pursuant to its previously announced share repurchase program. Subject to customary closing conditions, the sale of the notes is expected to close on or about December 9, 2015.

The notes will be sold only to qualified institutional buyers in the United States in reliance on Rule 144A under the Securities Act of 1933, and outside the United States to non-U.S. persons in reliance on Regulation S under the Securities Act. The proposed issuance of the notes will not be registered under the Securities Act, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sale of securities mentioned in this press release in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

This press release contains forward-looking statements relating to the consummation of the offering described above and the anticipated use of proceeds therefrom. Consummation of the offering is subject to a number of conditions, some of which are beyond Mylan's control. Therefore, no assurance can be given that the offering will be consummated on the terms described or at all, or that the proceeds will be able to be deployed as indicated.

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,400 generic and branded pharmaceuticals, including antiretroviral therapies on which nearly 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in approximately 165 countries and territories. Our global R&D and manufacturing platform includes more than 50 facilities, and we are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 30,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com.


'/>"/>
SOURCE Mylan N.V.
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. On World AIDS Day, Mylan Announces Plans to be the First to Market Newly-Recommended Antiretroviral Treatment for $99 Per Patient, Per Year
2. Mylan Completes Acquisition of Certain Businesses from Famy Care to Create a Leading Womens Healthcare Franchise
3. Mylan Authorizes $1 Billion Share Repurchase Plan
4. Perrigo Shareholders Convincingly Reject Mylans Tender Offer, Expressing Confidence in Perrigos Long-Term Strategy
5. Mylan Announces Results of Offer to Acquire Perrigo and Lapse of Offer
6. Mylan to Present at 24th Annual Credit Suisse Healthcare Conference
7. Perrigo Reaffirms Views on Mylans Inadequate Offer; Maintains Strong Recommendation Shareholders Not Tender
8. Perrigo Comments On Mylans Presentation
9. U.S. District Court Denies Perrigos Motion for Preliminary Injunction Related to Certain Mylan Disclosures
10. Mylan Third Quarter 2015 Constant Currency Adjusted Total Revenues Increase 36% and Adjusted Diluted EPS Increases 23% to $1.43
11. Mylan Appoints Ranjan Ray Chaudhuri as Global Commercial Lead for Mylans Over-the-Counter Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2019)... , ... October 10, 2019 , ... This World Sight ... Living with kathy ireland® is pleased to announce their recent interview with Brand ... showcasing how they help consumers of all abilities identify and choose effective hair care ...
(Date:10/9/2019)... ... October 09, 2019 , ... Drs. Steven White, Brad Haines ... with obstructive sleep apnea in Davidson, NC. If left untreated, sleep apnea ... under the care of a skilled dentist, those who suffer from snoring at night ...
(Date:10/8/2019)... ... October 08, 2019 , ... Help.org, a trusted online ... Best Rehab Facilities in Boston, Massachusetts for 2019. The informational guide recognizes the top ... , According to recent studies , drug overdose is the leading cause of ...
Breaking Medicine Technology:
(Date:10/8/2019)... ... 2019 , ... What unique insights can three former Surgeons General of the ... the nation? That question will be answered at ICAA 2019: Shaping the Future of ... event will take place October 10-12, 2019, at the Gaylord Palms Resort and Convention ...
(Date:10/8/2019)... Jose, CA (PRWEB) , ... October 08, 2019 , ... ... with gum disease in San Jose, CA experience relief from this common and treatable ... possible in order to save adults from living with uncomfortable symptoms, including tender and ...
(Date:10/8/2019)... ... October 08, 2019 , ... As a world-renowned expert ... associate professor with the University of Maryland Department of Veterinary Medicine, continues to ... Communications, Shi and his lab have discovered a new pathway by which liver ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... ... laboratory managers, administrators and pathologists, 4medica® President Gregg Church will inform ... the first-to-market solution reinventing labs orders management-by starting with the right, clean patient ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... Inc. a Digital Health Awards 1st Round (Top Ten) Finalist in its ... was to select companies that promote faster, better, more cost-effective healthcare by improving ...
Breaking Medicine News(10 mins):